CLOs on the Move

Hemispherx Biopharma

www.hemispherx.net

 
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Simione Consultants

Simione Consultants is a Hamden, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prexus Health

Prexus Health is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Celestiallabs

Celestiallabs Inc. is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cigna Global Health

Everything we do is around our mission to help you improve your health, wellbeing and peace of mind. We have extensive experience in managing varied and unique clinical and service situations worldwide. Our vast experience, coupled with our expertise, enables us to provide high standards of healthcare coverage, regardless of where you are in the world. Cigna International by the numbers: • Our international health insurance plans give you access to a global network of over 1.5 million hospitals, clinics and doctors. • Our employees serve over 160 million customers in key markets around the globe. • Our Customer Care Team is here for you 24/7, 365 days a year.

Regent Surgical Health

Since 2001, Regent Surgical Health has led the way in developing and managing successful surgery center partnerships. The ASC model is constantly evolving and Regent positions our facility partners to meet these changing market conditions and succeed. Today, a vast majority of our partnerships are Physician/Hospital Joint Ventures. Our experience has led us to develop proprietary ownership models that give both doctors and hospital administrators what they need to ensure long term clinical and financial success. Our success had earned us a reputation as Joint Venture Specialists. Regent has extensive knowledge of the ASC marketplace. We have found successful financial solutions to increase net revenues rather than using out of network strategies, pioneered new procedures such as spine, cardiology, gastric banding, and knee replacements into the ASC environment, and developed both majority and minority hospital partnerships. At Regent, our track record for successful ASC Turnarounds, De Novos, and Joint Ventures is unmatched.